This drug trial could drive you batty

Modern Healthcare - - OUTLIERS -

In timely news just weeks be­fore Hal­loween, a clin­i­cal re­search group said it is en­rolling pa­tients in a clin­i­cal trial to in­ves­ti­gate the im­pact of a vam­pire bat pro­tein for pa­tients who ex­pe­ri­enced an acute is­chemic stroke.

The plas­mino­gen ac­ti­va­tor, which is de­rived from the saliva of vam­pire bats, be­longs to a sub­stance class that sup­ports the break­down of blood clots, ac­cord­ing to the Neu­roS­tud­ies clin­i­cal re­search group. The only FDA-ap­proved treat­ment for acute is­chemic stroke must be ad­min­is­tered within three hours of the on­set of the symp-

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.